February 13, 2026

Pharvaris N.V. (PHVS) Stock Analysis: Potential Upside of 75% in the Biotech Sector

Pharvaris N.V. (PHVS), a Switzerland-based biotech firm, is generating buzz in the healthcare sector with its promising pipeline focused on rare diseases. With a market capitalization..

Xeris Biopharma Holdings (XERS) Investor Outlook: Aiming for a 61% Upside with Strong Buy Ratings

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is garnering significant attention in the biotechnology sector with its promising pipeline of therapies aimed at chronic endocrine and neurological..

Day One Biopharmaceuticals, Inc. (DAWN): Analyst Ratings Suggest 110% Upside Potential

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a rising player in the biotechnology sector, is drawing significant attention from investors thanks to a promising pipeline of treatments..

Iovance Biotherapeutics, Inc. (IOVA): A 261% Potential Upside Sparks Investor Interest

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is capturing the attention of the biotechnology investment community with its intriguing blend of innovative treatments and a substantial potential upside...

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating a 55% Revenue Surge with Caution

Exploring the dynamic realm of specialty and generic drug manufacturing, Avadel Pharmaceuticals plc (NASDAQ: AVDL) stands out with its significant market presence and compelling financial story...

Maravai LifeSciences Holdings (MRVI): Analyst Consensus and Growth Potential Amid Challenging Metrics

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent player in the biotechnology sector, has been a focal point for investors intrigued by its role in the..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Promising 62.78% Upside in Biotech Innovations

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a dynamic player in the biotechnology sector, is capturing investor attention with its promising pipeline in the treatment of inflammatory bowel..

Savara, Inc. (SVRA) Stock Analysis: Exploring an 85% Potential Upside in the Biotech Sector

Savara, Inc. (NASDAQ: SVRA) is gaining attention in the biotechnology sector, thanks to its focus on addressing rare respiratory diseases. With a market capitalization of $1.19..

CeriBell, Inc. (CBLL) Stock Analysis: A 41% Upside Potential in Revolutionary Medical Devices

CeriBell, Inc. (CBLL) is a burgeoning name within the healthcare sector, specifically in the medical devices industry, and is making waves with its innovative approach to..

SI-BONE, Inc. (SIBN) Stock Analysis: A 69.56% Potential Upside Amid Strong Buy Ratings

SI-BONE, Inc. (NASDAQ: SIBN), a healthcare industry contender specializing in medical devices, presents an intriguing opportunity for investors eyeing the growing field of musculoskeletal disorder treatments...

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 103% Potential Upside in Health Information Services

Simulations Plus, Inc. (SLP), a prominent player in the healthcare sector, has emerged as a compelling choice for investors seeking potential growth in the Health Information..

GH Research PLC (GHRS) Stock Analysis: Potential Upside of 124.74% and Strong Buy Ratings

Investors seeking opportunities in the healthcare sector should pay attention to GH Research PLC (NASDAQ: GHRS), a promising player in the biotechnology industry. Based in Dublin,..

uniQure N.V. (QURE) Stock Report: Exploring a 138% Potential Upside in the Biotech Arena

For investors with an eye on the biopharmaceutical sector, uniQure N.V. (NASDAQ: QURE) presents a compelling opportunity, marked by a significant potential upside of 138.58%. This..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Evaluating a 52.34% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Enliven Therapeutics, Inc. (NASDAQ: ELVN) a compelling opportunity, as the company is currently positioned with a..

STAAR Surgical Company (STAA) Stock Analysis: Exploring a 37.81% Potential Upside for Investors

STAAR Surgical Company (NASDAQ: STAA), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing investment opportunity despite recent market..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 20% Upside Potential in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD) has carved out a niche in the healthcare sector, specifically within the medical devices industry, by focusing on MRI-compatible equipment. Headquartered in..

Golden Matrix secures Latin American distribution through Brazino777 agreement

Golden Matrix expands its distribution network in Latin America through a new Expanse Studios partnership with Brazino777...

Immunome, Inc. (IMNM) Stock Analysis: A 56% Upside Potential in Biotechnology

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology company, is making waves in the healthcare sector with a focus on developing targeted cancer therapies. With a current..

Nutex Health Inc. (NUTX): Investor Outlook Highlights a Promising 138% Potential Upside

As healthcare remains a pivotal sector in the global economy, Nutex Health Inc. (NUTX) emerges as an intriguing player with a significant growth narrative. Operating within..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Emerging Potential with 90% Upside

For investors with a keen eye on the biotechnology sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents an intriguing opportunity. Headquartered in Brisbane, California, this clinical-stage biopharmaceutical..

Search

Funds

February 13, 2026

Golden Matrix secures Latin American distribution through Brazino777 agreement

Golden Matrix expands its distribution network in Latin America through a new Expanse Studios partnership with Brazino777...
Search

Funds

February 13, 2026

FTSE 100

Funds